Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Datapult is a public health informatics and healthcare data technology company launched in 2022 as a wholly owned subsidiary of the Association of Public Health Laboratories (APHL). The company provides electronic laboratory reporting, test reporting, data exchange, and related informatics services through the APHL Informatics Messaging Services (AIMS) platform. Its products are designed to improve the quality, interoperability, and timeliness of laboratory and public health data shared among laboratories, agencies, and clinical partners. Datapult has supported reporting for COVID-19 and mpox, is expanding to nationally notifiable diseases and other reportable conditions, and also hosts a clinically validated tuberculosis bioinformatics pipeline developed by New York's Wadsworth Center. The company appears to operate as a commercial public-health-focused software and data services business rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Datapult.